DE1199564T1 - Verfahren zum Screenen von Substanzen die einen effekt auf intrazelluläre Translokation haben - Google Patents
Verfahren zum Screenen von Substanzen die einen effekt auf intrazelluläre Translokation habenInfo
- Publication number
- DE1199564T1 DE1199564T1 DE1199564T DE01204477T DE1199564T1 DE 1199564 T1 DE1199564 T1 DE 1199564T1 DE 1199564 T DE1199564 T DE 1199564T DE 01204477 T DE01204477 T DE 01204477T DE 1199564 T1 DE1199564 T1 DE 1199564T1
- Authority
- DE
- Germany
- Prior art keywords
- cells
- luminophore
- substance
- change
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract 39
- 239000000126 substance Substances 0.000 title claims 14
- 230000005945 translocation Effects 0.000 title claims 6
- 230000000694 effects Effects 0.000 title claims 2
- 230000003834 intracellular effect Effects 0.000 title claims 2
- 238000012216 screening Methods 0.000 title claims 2
- 239000005090 green fluorescent protein Substances 0.000 claims abstract 10
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims abstract 6
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims abstract 6
- 230000031146 intracellular signal transduction Effects 0.000 claims abstract 6
- 238000005259 measurement Methods 0.000 claims abstract 5
- 238000002165 resonance energy transfer Methods 0.000 claims abstract 4
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims abstract 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims abstract 2
- 102000001253 Protein Kinase Human genes 0.000 claims abstract 2
- 108091023040 Transcription factor Proteins 0.000 claims abstract 2
- 102000040945 Transcription factor Human genes 0.000 claims abstract 2
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims abstract 2
- 230000010287 polarization Effects 0.000 claims abstract 2
- 108060006633 protein kinase Proteins 0.000 claims abstract 2
- 210000004027 cell Anatomy 0.000 claims 29
- 230000008859 change Effects 0.000 claims 15
- 230000004913 activation Effects 0.000 claims 5
- 230000004071 biological effect Effects 0.000 claims 4
- 230000006662 intracellular pathway Effects 0.000 claims 4
- 229920001184 polypeptide Polymers 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 230000008827 biological function Effects 0.000 claims 3
- 210000004962 mammalian cell Anatomy 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 238000011534 incubation Methods 0.000 claims 2
- 238000003672 processing method Methods 0.000 claims 2
- 230000004044 response Effects 0.000 claims 2
- 230000002588 toxic effect Effects 0.000 claims 2
- 241000238631 Hexapoda Species 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims 1
- 229940088623 biologically active substance Drugs 0.000 claims 1
- 244000309464 bull Species 0.000 claims 1
- 230000030570 cellular localization Effects 0.000 claims 1
- 230000036755 cellular response Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000003436 cytoskeletal effect Effects 0.000 claims 1
- 230000009849 deactivation Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 238000000799 fluorescence microscopy Methods 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000006525 intracellular process Effects 0.000 claims 1
- 238000004020 luminiscence type Methods 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 238000012545 processing Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102220054792 rs138065384 Human genes 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 231100000167 toxic agent Toxicity 0.000 claims 1
- 239000003440 toxic substance Substances 0.000 claims 1
- 238000012546 transfer Methods 0.000 claims 1
- 210000005253 yeast cell Anatomy 0.000 claims 1
- -1 PKA Proteins 0.000 abstract 3
- 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 abstract 2
- 108010085238 Actins Proteins 0.000 abstract 1
- 102000007469 Actins Human genes 0.000 abstract 1
- 101100356682 Caenorhabditis elegans rho-1 gene Proteins 0.000 abstract 1
- 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 abstract 1
- 102000004654 Cyclic GMP-Dependent Protein Kinases Human genes 0.000 abstract 1
- 108010003591 Cyclic GMP-Dependent Protein Kinases Proteins 0.000 abstract 1
- 102000015792 Cyclin-Dependent Kinase 2 Human genes 0.000 abstract 1
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 abstract 1
- 101100366888 Dictyostelium discoideum dstA gene Proteins 0.000 abstract 1
- 101000652725 Drosophila melanogaster Transcription initiation factor TFIID subunit 5 Proteins 0.000 abstract 1
- 102220566687 GDNF family receptor alpha-1_F64L_mutation Human genes 0.000 abstract 1
- 102220566469 GDNF family receptor alpha-1_S65T_mutation Human genes 0.000 abstract 1
- 102220566451 GDNF family receptor alpha-1_Y66H_mutation Human genes 0.000 abstract 1
- 101150033606 Grk5 gene Proteins 0.000 abstract 1
- 101000752722 Homo sapiens Apoptosis-stimulating of p53 protein 1 Proteins 0.000 abstract 1
- 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 abstract 1
- 101001120056 Homo sapiens Phosphatidylinositol 3-kinase regulatory subunit alpha Proteins 0.000 abstract 1
- 101001120097 Homo sapiens Phosphatidylinositol 3-kinase regulatory subunit beta Proteins 0.000 abstract 1
- 101001116549 Homo sapiens Protein CBFA2T2 Proteins 0.000 abstract 1
- 101001000998 Homo sapiens Protein phosphatase 1 regulatory subunit 12C Proteins 0.000 abstract 1
- 101000927796 Homo sapiens Rho guanine nucleotide exchange factor 7 Proteins 0.000 abstract 1
- 101001046426 Homo sapiens cGMP-dependent protein kinase 1 Proteins 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- 101150101215 Mapk8 gene Proteins 0.000 abstract 1
- 101100268066 Mus musculus Zap70 gene Proteins 0.000 abstract 1
- 102000002001 Non-Receptor Type 6 Protein Tyrosine Phosphatase Human genes 0.000 abstract 1
- 108010015793 Non-Receptor Type 6 Protein Tyrosine Phosphatase Proteins 0.000 abstract 1
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 101710113459 RAC-alpha serine/threonine-protein kinase Proteins 0.000 abstract 1
- 101150111584 RHOA gene Proteins 0.000 abstract 1
- 229940100514 Syk tyrosine kinase inhibitor Drugs 0.000 abstract 1
- 102100021164 Vasodilator-stimulated phosphoprotein Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002596 correlated effect Effects 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004068 intracellular signaling Effects 0.000 abstract 1
- 239000003226 mitogen Substances 0.000 abstract 1
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 abstract 1
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 125000003607 serino group Chemical class [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 abstract 1
- 229960002898 threonine Drugs 0.000 abstract 1
- 108010054220 vasodilator-stimulated phosphoprotein Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5035—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on sub-cellular localization
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
- G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK39297 | 1997-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1199564T1 true DE1199564T1 (de) | 2003-11-27 |
Family
ID=8092994
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1199564T Pending DE1199564T1 (de) | 1997-04-07 | 1998-04-07 | Verfahren zum Screenen von Substanzen die einen effekt auf intrazelluläre Translokation haben |
| DE69804446T Expired - Fee Related DE69804446T3 (de) | 1997-04-07 | 1998-04-07 | Verfahren um quantitativen informationen über einflüsse auf zelluläre reaktionen zu entnehmen |
| DE69837118T Expired - Fee Related DE69837118T2 (de) | 1997-04-07 | 1998-04-07 | Ein Verfahren zum Screenen von Substanzen hinsichtlich ihres Effekts auf cAMP Spiegel basierend auf intrazellulärer Translokation von PKA |
| DE69824763T Expired - Lifetime DE69824763T2 (de) | 1997-04-07 | 1998-04-07 | Verfahren zum Screenen von Substanzen die einen effekt auf intrazelluläre Translokation haben |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69804446T Expired - Fee Related DE69804446T3 (de) | 1997-04-07 | 1998-04-07 | Verfahren um quantitativen informationen über einflüsse auf zelluläre reaktionen zu entnehmen |
| DE69837118T Expired - Fee Related DE69837118T2 (de) | 1997-04-07 | 1998-04-07 | Ein Verfahren zum Screenen von Substanzen hinsichtlich ihres Effekts auf cAMP Spiegel basierend auf intrazellulärer Translokation von PKA |
| DE69824763T Expired - Lifetime DE69824763T2 (de) | 1997-04-07 | 1998-04-07 | Verfahren zum Screenen von Substanzen die einen effekt auf intrazelluläre Translokation haben |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6518021B1 (OSRAM) |
| EP (3) | EP0986753B2 (OSRAM) |
| JP (1) | JP2001522454A (OSRAM) |
| AT (3) | ATE269975T1 (OSRAM) |
| AU (1) | AU6820998A (OSRAM) |
| CA (1) | CA2286293C (OSRAM) |
| DE (4) | DE1199564T1 (OSRAM) |
| DK (2) | DK0986753T4 (OSRAM) |
| ES (2) | ES2173573T5 (OSRAM) |
| PT (2) | PT986753E (OSRAM) |
| WO (1) | WO1998045704A2 (OSRAM) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2177922T3 (es) | 1996-01-26 | 2002-12-16 | Virco Bvba | Metodo de valoracion la quimioterapia de pacientes hiv-positivos basado en la sensibilidad fenotipica a los farmacos de las cepas de hiv delpaciente. |
| US7062219B2 (en) * | 1997-01-31 | 2006-06-13 | Odyssey Thera Inc. | Protein fragment complementation assays for high-throughput and high-content screening |
| US6416959B1 (en) | 1997-02-27 | 2002-07-09 | Kenneth Giuliano | System for cell-based screening |
| US6759206B1 (en) | 1997-02-27 | 2004-07-06 | Cellomics, Inc. | System for cell-based screening |
| US7853411B2 (en) | 1997-02-27 | 2010-12-14 | Cellomics, Inc. | System for cell-based screening |
| DK0986753T4 (da) * | 1997-04-07 | 2005-12-19 | Bioimage As | Fremgangsmåde til uddragning af kvantitativ information, hvad angår en påvirkning af et cellulært respons |
| US7160687B1 (en) | 1997-05-29 | 2007-01-09 | Cellomics, Inc. | Miniaturized cell array methods and apparatus for cell-based screening |
| US6235512B1 (en) * | 1997-07-01 | 2001-05-22 | Tularik Inc. | IKK-α proteins, nucleic acids and methods |
| US20050221280A1 (en) | 1998-02-02 | 2005-10-06 | Odyssey Thera, Inc. | Protein-protein interactions for pharmacological profiling |
| US20030036855A1 (en) | 1998-03-16 | 2003-02-20 | Praelux Incorporated, A Corporation Of New Jersey | Method and apparatus for screening chemical compounds |
| US6388788B1 (en) | 1998-03-16 | 2002-05-14 | Praelux, Inc. | Method and apparatus for screening chemical compounds |
| AU765703B2 (en) * | 1998-03-27 | 2003-09-25 | Bruce J. Bryan | Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| US6037133A (en) * | 1998-04-17 | 2000-03-14 | Clontech Laboratories, Inc. | IκBEGFP constructs, cell lines and methods of use |
| US20030220258A1 (en) | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
| US8680059B2 (en) * | 1998-05-20 | 2014-03-25 | Biotempt B.V. | Oligopeptide acetate and formulations thereof |
| US6844315B2 (en) * | 1998-05-20 | 2005-01-18 | Erasmus Universiteit Rotterdam | Immunoregulator |
| AU6189599A (en) * | 1998-10-15 | 2000-05-08 | Bioimage A/S | An improved method for extracting quantitative information relating to an influence on a cellular response |
| WO2000023091A2 (en) * | 1998-10-15 | 2000-04-27 | Bioimage A/S | Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| GB9901072D0 (en) * | 1999-01-19 | 1999-03-10 | Imp Cancer Res Tech | Methods for detecting changes to a macromolecular component of a cell |
| IL144797A0 (en) * | 1999-02-26 | 2002-06-30 | Cellomics Inc | A system for cell-based screening |
| DE19915310A1 (de) * | 1999-04-03 | 2000-10-05 | Bayer Ag | Diffusionskontrollierende Sensorschicht |
| DE69906253D1 (de) * | 1999-04-29 | 2003-04-30 | Univ Erasmus | Bestimmung von Analytbeweglichkeit |
| US6743576B1 (en) | 1999-05-14 | 2004-06-01 | Cytokinetics, Inc. | Database system for predictive cellular bioinformatics |
| US20030228565A1 (en) * | 2000-04-26 | 2003-12-11 | Cytokinetics, Inc. | Method and apparatus for predictive cellular bioinformatics |
| US6651008B1 (en) | 1999-05-14 | 2003-11-18 | Cytokinetics, Inc. | Database system including computer code for predictive cellular bioinformatics |
| AU4847100A (en) * | 1999-05-14 | 2000-12-05 | Cytokinetics, Inc. | Method and apparatus for predictive cellular bioinformatics |
| US7151847B2 (en) | 2001-02-20 | 2006-12-19 | Cytokinetics, Inc. | Image analysis of the golgi complex |
| EP1055929A1 (en) * | 1999-05-26 | 2000-11-29 | Tibotec N.V. | Means and methods for drug discovery and the phenotypic characterisation of cells |
| US6573059B1 (en) * | 1999-06-04 | 2003-06-03 | Rmf Dictagene S.A. | Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements |
| AU5870800A (en) * | 1999-06-09 | 2000-12-28 | Ljl Biosystems, Inc. | Cell-signaling assays |
| US6673554B1 (en) * | 1999-06-14 | 2004-01-06 | Trellie Bioinformatics, Inc. | Protein localization assays for toxicity and antidotes thereto |
| AU7131900A (en) * | 1999-06-21 | 2001-01-09 | Cellomics, Inc. | A system for cell-based screening |
| US6121047A (en) * | 1999-07-21 | 2000-09-19 | Isis Pharmaceuticals Inc. | Antisense modulation of SHP-1 expression |
| US6489151B1 (en) * | 2000-03-27 | 2002-12-03 | The Research Foundation Of State University Of New York | Biologically active alternative form of the IKKα IκB kinase |
| EP1300418A1 (en) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Gene regulation by oligopeptides |
| KR100414641B1 (ko) * | 2000-04-07 | 2004-01-13 | 동부한농화학 주식회사 | 형질전환식물체의 생체분석방법 및 그를 이용한 시스템 |
| WO2001079526A2 (en) * | 2000-04-17 | 2001-10-25 | Bioimage A/S | Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| WO2001081917A2 (en) * | 2000-04-26 | 2001-11-01 | Bioimage A/S | Chemical signal enhancement of dynamic intensity-based intracellular protein- and fluorophore-based redistribution assays for drug screening |
| AU2001270126A1 (en) * | 2000-06-23 | 2002-01-08 | Cytokinetics, Inc. | Image analysis for phenotyping sets of mutant cells |
| CA2414626A1 (en) | 2000-07-04 | 2002-01-10 | Bioimage A/S | A method for extracting quantitative information relating to interactions between cellular components |
| US7625951B2 (en) | 2000-07-13 | 2009-12-01 | University Of Kentucky Research Foundation | Stimuli-responsive hydrogel microdomes integrated with genetically engineered proteins for high-throughput screening of pharmaceuticals |
| DE10037759A1 (de) * | 2000-08-03 | 2002-07-04 | Gruenenthal Gmbh | Screeningverfahren |
| KR100414781B1 (ko) * | 2000-11-24 | 2004-01-13 | 재단법인서울대학교산학협력재단 | ＮＦ-κＢ 발현을 인간 피부세포에서 정량적으로 측정하기위한 안정한 분석시스템 및 그의 용도 |
| US7218764B2 (en) | 2000-12-04 | 2007-05-15 | Cytokinetics, Inc. | Ploidy classification method |
| US6956961B2 (en) | 2001-02-20 | 2005-10-18 | Cytokinetics, Inc. | Extracting shape information contained in cell images |
| US7016787B2 (en) | 2001-02-20 | 2006-03-21 | Cytokinetics, Inc. | Characterizing biological stimuli by response curves |
| US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
| US7244614B2 (en) | 2001-08-01 | 2007-07-17 | Cellomics, Inc. | Fusion proteins and assays for molecular binding |
| WO2003050535A2 (de) * | 2001-12-10 | 2003-06-19 | Evotec Oai Ag | Verfahren zur bestimmung von einflüssen unphysiologischer verbindungen, deren derivate und abbauprodukte auf organismen, organe und zellen |
| US7176303B2 (en) * | 2003-11-06 | 2007-02-13 | Isis Pharmaceuticals, Inc. | Modulation of STAT5 expression |
| US7786084B2 (en) * | 2001-12-21 | 2010-08-31 | Biotempt B.V. | Treatment of burns |
| US20080242837A1 (en) * | 2001-12-21 | 2008-10-02 | Khan Nisar A | Peptide compositions |
| US20030220257A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of trauma |
| US20080318871A1 (en) * | 2001-12-21 | 2008-12-25 | Khan Nisar A | Treatment of neurological disorders |
| US7560433B2 (en) | 2001-12-21 | 2009-07-14 | Biotempt B.V. | Treatment of multiple sclerosis (MS) |
| CA2413475C (en) | 2002-04-25 | 2010-07-27 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Zap-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll) |
| GB0216674D0 (en) * | 2002-07-18 | 2002-08-28 | Amersham Biosciences Uk Ltd | Functional screening method |
| US8168568B1 (en) | 2003-03-10 | 2012-05-01 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Combinatorial therapy for protein signaling diseases |
| EP1646926A2 (en) | 2003-07-18 | 2006-04-19 | Cytokinetics, Inc. | Characterizing biological stimuli by response curves |
| US20050014217A1 (en) | 2003-07-18 | 2005-01-20 | Cytokinetics, Inc. | Predicting hepatotoxicity using cell based assays |
| US7235353B2 (en) | 2003-07-18 | 2007-06-26 | Cytokinetics, Inc. | Predicting hepatotoxicity using cell based assays |
| US20050060100A1 (en) * | 2003-09-15 | 2005-03-17 | Becton Dickinson And Company | Computer software and algorithms for systems biologically linked to cellular phenotype |
| US20050059083A1 (en) * | 2003-09-15 | 2005-03-17 | Becton Dickinson And Company | High throughput method to identify ligands for cell attachment |
| US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
| US8586294B2 (en) | 2004-05-18 | 2013-11-19 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of protein translocation by beta-galactosidase reporter fragment complementation |
| US7323318B2 (en) | 2004-07-15 | 2008-01-29 | Cytokinetics, Inc. | Assay for distinguishing live and dead cells |
| US8084260B2 (en) * | 2004-11-24 | 2011-12-27 | Applied Biosystems, Llc | Spectral calibration method and system for multiple instruments |
| JP4846799B2 (ja) * | 2005-07-05 | 2011-12-28 | バイオテンプト ベー．フェー． | 腫瘍の治療 |
| US20080227131A1 (en) * | 2005-10-28 | 2008-09-18 | Ge Healthcare Uk Limited | Signalling Assay and Cell Line |
| WO2008018905A2 (en) * | 2006-01-17 | 2008-02-14 | Cellumen, Inc. | Method for predicting biological systems responses |
| EP1864692A1 (en) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
| US8114615B2 (en) | 2006-05-17 | 2012-02-14 | Cernostics, Inc. | Method for automated tissue analysis |
| US20100112602A1 (en) * | 2006-11-10 | 2010-05-06 | Taylor Lansing D | Protein-Protein Interaction Biosensors and Methods of Use Thereof |
| US20100178652A1 (en) * | 2007-01-05 | 2010-07-15 | Litherland Sally A | Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease |
| PT2120991E (pt) * | 2007-02-12 | 2014-05-02 | Biotempt Bv | Tratamento d a hemorragia traumática com oligopéptidos curtos |
| US20080217002A1 (en) * | 2007-03-07 | 2008-09-11 | Floyd Randolph Simonds | Sand control screen having a micro-perforated filtration layer |
| JP5438962B2 (ja) * | 2008-12-25 | 2014-03-12 | シスメックス株式会社 | 細胞画像表示装置 |
| US8574837B2 (en) | 2008-12-29 | 2013-11-05 | President And Fellows Of Harvard College | System for screening agonists/antagonists of cellular signaling pathways |
| KR101088605B1 (ko) | 2009-06-30 | 2011-11-30 | 한국산업기술대학교산학협력단 | 2대의 카메라를 이용한 세포 조작 방법 |
| JP5089713B2 (ja) * | 2010-01-18 | 2012-12-05 | シャープ株式会社 | 画像圧縮装置、圧縮画像出力装置、画像圧縮方法、コンピュータプログラム及び記録媒体 |
| ES2739623T3 (es) | 2011-03-17 | 2020-02-03 | Cernostics Inc | Sistemas y composiciones para diagnosticar el esófago de Barrett y métodos para usarlos |
| EP2825887A4 (en) | 2012-03-15 | 2015-08-19 | Montana Molecular Llc | GENETICALLY-CODED, FLUORESCENT SENSORS FOR THE DETECTION OF INTRA-CELLULAR SIGNALS BY DIACYLGLYCEROL SIGNAL PATHS |
| EP2682187B1 (en) * | 2012-07-02 | 2017-09-13 | Molecular Devices, LLC | Selection method and apparatus |
| CA2929392A1 (en) | 2013-11-04 | 2015-05-07 | Montana Molecular Llc | Genetically encoded fluorescent sensors for detecting ligand bias and intracellular signaling through camp pathways |
| DE102014012130B3 (de) | 2014-08-13 | 2015-03-05 | Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung | Nachweisverfahren unter Verwendung von rekombinanten lebenden Zellen zum Nachweis von xenobiotischen Stoffen sowie Anordnung und Testkit zur Durchführung des Nachweisverfahrens |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT321257B (de) | 1971-05-26 | 1975-03-25 | Koreska Gmbh W | Anlage zur Rückgewinnung flüchtiger Lösungsmittel |
| JPS57198544A (en) * | 1981-05-28 | 1982-12-06 | Sony Corp | Manufacture of magnetic recording medium |
| DE3240063A1 (de) | 1981-11-02 | 1983-05-26 | Basf Ag, 6700 Ludwigshafen | Vorrichtung zur herstellung eines magnetogrammtraegers |
| JPS5880136A (ja) * | 1981-11-02 | 1983-05-14 | Fuji Photo Film Co Ltd | 磁気記録材料の製造方法 |
| JPH0656656B2 (ja) * | 1983-10-03 | 1994-07-27 | 富士写真フイルム株式会社 | 磁気記録媒体の製造方法 |
| JPS6292132A (ja) * | 1985-10-18 | 1987-04-27 | Fuji Photo Film Co Ltd | 磁気記録媒体の製造方法 |
| US4923766A (en) * | 1988-03-29 | 1990-05-08 | Canon Kabushiki Kaisha | Process for preparing magnetic recording |
| GB8916806D0 (en) * | 1989-07-22 | 1989-09-06 | Univ Wales Medicine | Modified proteins |
| DE4009797A1 (de) * | 1990-03-27 | 1991-10-02 | Pagendarm Gmbh | Verfahren und anordnung zum kondensieren von dampffoermigen substanzen |
| AU677834B2 (en) * | 1993-04-07 | 1997-05-08 | Cancer Research Ventures Limited | Methods for screening of substances for therapeutic activityand yeast for use therein |
| AU694745B2 (en) * | 1993-09-10 | 1998-07-30 | Trustees Of Columbia University In The City Of New York, The | Uses of green fluorescent protein |
| DE69534920T2 (de) * | 1994-07-22 | 2007-04-05 | University Of North Carolina | Src SH3 BINDENDE PEPTIDE UND VERFAHREN ZU IHRER ISOLIERUNG UND VERWENDUNG |
| US6184205B1 (en) * | 1994-07-22 | 2001-02-06 | University Of North Carolina At Chapel Hill | GRB2 SH3 binding peptides and methods of isolating and using same |
| US5874231A (en) * | 1994-08-22 | 1999-02-23 | Mcgill University | Methods of screening for non-hormone compounds which effect modulation of polypeptide translation |
| US5958713A (en) | 1995-01-31 | 1999-09-28 | Novo Nordisk A/S | Method of detecting biologically active substances by using green fluorescent protein |
| ATE211506T1 (de) * | 1995-01-31 | 2002-01-15 | Bioimage As | Ein verfahren zum nachweis biologisch aktiver substanzen |
| DE69604298T2 (de) * | 1995-09-22 | 2000-05-18 | Bioimage A/S, Soeborg | Varianten des grünen fluoreszenzproteins, gfp |
| WO1997020931A1 (en) * | 1995-12-08 | 1997-06-12 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Method and compositions for monitoring dna binding molecules in living cells |
| US5874304A (en) * | 1996-01-18 | 1999-02-23 | University Of Florida Research Foundation, Inc. | Humanized green fluorescent protein genes and methods |
| US5989835A (en) * | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
| EP0915989B1 (en) * | 1996-07-16 | 2010-06-02 | The Regents Of The University Of California | Assays for protein kinases using fluorescent protein substrates |
| WO1998030715A1 (en) * | 1997-01-07 | 1998-07-16 | California Institute Of Technology | Optical sensors of cell signaling |
| WO1998038490A1 (en) * | 1997-02-27 | 1998-09-03 | Cellomics, Inc. | A system for cell-based screening |
| US6416959B1 (en) * | 1997-02-27 | 2002-07-09 | Kenneth Giuliano | System for cell-based screening |
| DK0986753T4 (da) * | 1997-04-07 | 2005-12-19 | Bioimage As | Fremgangsmåde til uddragning af kvantitativ information, hvad angår en påvirkning af et cellulært respons |
| WO2000049183A1 (en) * | 1999-02-17 | 2000-08-24 | Clontech Laboratories, Inc. | FLUORESCENCE RESONANCE ENERGY TRANSFER DETECTION OF cAMP IN LIVING CELLS USING GFP VARIANTS |
| US6573059B1 (en) * | 1999-06-04 | 2003-06-03 | Rmf Dictagene S.A. | Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements |
-
1998
- 1998-04-07 DK DK98913541T patent/DK0986753T4/da active
- 1998-04-07 EP EP98913541A patent/EP0986753B2/en not_active Expired - Lifetime
- 1998-04-07 DE DE1199564T patent/DE1199564T1/de active Pending
- 1998-04-07 ES ES98913541T patent/ES2173573T5/es not_active Expired - Lifetime
- 1998-04-07 DE DE69804446T patent/DE69804446T3/de not_active Expired - Fee Related
- 1998-04-07 DE DE69837118T patent/DE69837118T2/de not_active Expired - Fee Related
- 1998-04-07 AU AU68209/98A patent/AU6820998A/en not_active Abandoned
- 1998-04-07 EP EP01204477A patent/EP1199564B1/en not_active Expired - Lifetime
- 1998-04-07 PT PT98913541T patent/PT986753E/pt unknown
- 1998-04-07 CA CA002286293A patent/CA2286293C/en not_active Expired - Lifetime
- 1998-04-07 AT AT01204477T patent/ATE269975T1/de not_active IP Right Cessation
- 1998-04-07 DK DK03028919T patent/DK1435519T3/da active
- 1998-04-07 AT AT03028919T patent/ATE354089T1/de not_active IP Right Cessation
- 1998-04-07 EP EP03028919A patent/EP1435519B1/en not_active Expired - Lifetime
- 1998-04-07 PT PT01204477T patent/PT1199564E/pt unknown
- 1998-04-07 DE DE69824763T patent/DE69824763T2/de not_active Expired - Lifetime
- 1998-04-07 AT AT98913541T patent/ATE215227T1/de not_active IP Right Cessation
- 1998-04-07 ES ES01204477T patent/ES2191575T3/es not_active Expired - Lifetime
- 1998-04-07 JP JP54227698A patent/JP2001522454A/ja active Pending
- 1998-04-07 WO PCT/DK1998/000145 patent/WO1998045704A2/en not_active Ceased
-
1999
- 1999-10-07 US US09/417,197 patent/US6518021B1/en not_active Expired - Lifetime
-
2002
- 2002-02-05 US US10/072,036 patent/US8058008B2/en not_active Expired - Fee Related
-
2007
- 2007-10-29 US US11/927,246 patent/US20090023598A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69804446T2 (de) | Verfahren um quantitativen informationen über einflüsse auf zelluläre reaktionen zu entnehmen | |
| DE69824174T2 (de) | Ein system zur zellbasierten reihenuntersuchung | |
| DE69722800T2 (de) | Probenanalyseverfahren mittels bestimmung einer funktion der spezifischen helligkeit | |
| Galizia et al. | Odour coding is bilaterally symmetrical in the antennal lobes of honeybees (Apis mellifera) | |
| Yang et al. | Genetically encoded voltage indicators: opportunities and challenges | |
| DE60023905T2 (de) | Optische Systemanalyse von Zellen | |
| DE60002562T2 (de) | Ein system für zellbasierte reihenuntersuchungen | |
| DE69729469T2 (de) | Zellbasierter festphasenassay | |
| Castorena et al. | Micromapping of microbial hotspots and biofilms from different crops using digital image mosaics of soil thin sections | |
| EP0819930A2 (de) | Verfahren und Vorrichtung zum Screening von Molekülen bezüglich ihres individuellen Bindungsverhaltens zu mindestens einem vorgegebenen Ligand | |
| DE102010052975A1 (de) | Verfahren und Probenträger für die Unterstützung der händischen Präparation von Proben für eine Ionisierung mit matrix-unterstützter Laserdesorption | |
| WO2003006684A2 (de) | Vorrichtung und verfahren zum nachweis der photosynthese-hemmung | |
| WO2010081690A1 (de) | Verfahren und system zur charakterisierung einer probe mittels bildgebender fluoreszenzmikroskopie | |
| DE69935436T2 (de) | Verfahren zum nachweis von mikroorganismen | |
| DE102010061182B4 (de) | Sensoranordnung, Verfahren und Messsystem zur Erfassung der Verteilung wenigstens einer Veränderlichen eines Objekts | |
| DE10023423A1 (de) | Direkter Nachweis von Einzelmolekülen | |
| Perry et al. | A scanning proton microprobe study of macrohairs from the lemma of the grass Phalaris canariensis L | |
| EP2167940A1 (de) | Verfahren zum bestimmen eines messwerts auf der basis von einzelmolekülereignissen | |
| DE102012100098B4 (de) | Verfahren zur Aufzeichnung von zeitlichen Änderungen der Zeitfunktion eines optischen Signals mit räumlicher Auflösung entlang einer Linie im Raum | |
| EP1504259B1 (en) | Method for the determination of changes in a cellular morphological parameter | |
| DE60117180T2 (de) | Verfahren zur messung des aktivierungszustands von signalwegen in zellen | |
| WO2003080789A1 (de) | Vorrichtung und verfahren zur detektion von zellulären vorgängen mittels lumineszenzmessungen | |
| DE102013202206A1 (de) | Methode zur Inhibierung des Proteins SWAP-70 | |
| DE69614449T2 (de) | Verfahren zur Messung der mikrobiellen Aktivität | |
| DE102006045607A1 (de) | Verfahren zur räumlich hochauflösenden Untersuchung von einer mit einer fluoreszierenden Substanz markierten Struktur einer Probe |